Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Twist Bioscience Corp shares valued at $71,933 were purchased by Leproust Emily M. on Mar 20 ’25. At $41.68 per share, Leproust Emily M. acquired 1,726 shares.
Also, Cho Dennis purchased 230 shares, netting a total of over 9,585 in proceeds.
Before that, Green Paula had added 291 shares to its account. In a trade valued at $12,128, the Officer bought Twist Bioscience Corp shares for $41.68 each.
As published in their initiating research note from Wolfe Research on December 13, 2024, Twist Bioscience Corp [TWST] has been an Outperform and the price target has been revised to $60. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in early June. As of January 17, 2024, Goldman has increased its “Neutral” rating to a “Buy” for TWST. Earlier on September 27, 2023, Berenberg initiated its rating. Their recommendation was “a Buy” for TWST stock.
Analyzing TWST Stock Performance
During the last five days, there has been a surge of approximately 7.49%. Over the course of the year, Twist Bioscience Corp shares have dropped approximately -9.51%. Shares of the company reached a 52-week high of $55.33 on 01/24/25 and a 52-week low of $34.35 on 03/04/25. A 50-day SMA is recorded $45.32, while a 200-day SMA reached $46.44.
Support And Resistance Levels for Twist Bioscience Corp (TWST)
According to the 24-hour chart, there is a support level at 40.82, which, if violated, would cause prices to drop to 39.59. In the upper region, resistance lies at 43.19. The next price resistance is at 44.33. RSI (Relative Strength Index) is 49.84 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.56, which suggests the price will increase in the coming days. Percent R is at 13.77%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
